Long-term survival of high-risk melanoma patients immunized with a Hyper-IL-6-modified allogeneic whole-cell vaccine after complete resection

Author: Mackiewicz Andrzej   Mackiewicz Jacek   Wysocki Piotr J.   Wiznerowicz Maciej   Kapcinska Malgorzata   Laciak Maria   Rose-John Stefan   Izycki Dariusz   Burzykowski Tomasz   Karczewska-Dzionk Aldona  

Publisher: Informa Healthcare

ISSN: 1354-3784

Source: Expert Opinion on Investigational Drugs, Vol.21, Iss.6, 2012-06, pp. : 773-783

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content